| Conference – The Alpha Stem Cell Clinic Annual Symposium | University of California, Davis | CIRM – Leading the New Era of Living Medicines |
$6,738 |
| Alpha Stem Cell Clinics Network Expansion | University of California, Davis | Alpha Stem Cell Clinic for Northern and Central California |
$7,999,997 |
| Alpha Stem Cell Clinics Network Expansion | University of California, Davis | Alpha Stem Cell Clinic for Northern and Central California |
$8,076,421 |
| Clinical Trial Stage Projects | University of California, Davis | Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-selected CD34+ Cells in AIDS lymphoma patients |
$8,414,265 |
| Late Stage Preclinical Projects | University of California, Davis | Superior forward-oriented b-globin vector for treating Sickle Cell Disease |
$4,598,398 |
| Disease Team Therapy Planning I | University of California, Davis | Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients |
$66,880 |
